Hayden Royal »

United Therapeutics Corporation shares owned by Hayden Royal

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Hayden Royal from 13F filings

Historical chart of Hayden Royal investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Hayden Royal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Hayden Royal

Quarter filed Position value Share count Share price at filing
2021-12-31 $174k 806 215.88

More positions owned by Hayden Royal

iShares S&P 500 Growth Exchange Traded Fund (IVW)
iShares S&P 500 Value Exchange Traded Fund (IVE)
Spdr S&p 500 Etf Exchange Traded Fund (SPY)
iShares S&P Small-Cap 600 Growth ETF Exchange Traded Fund (IJT)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
iShares S&P Small-Cap 600 Value ETF Exchange Traded Fund (IJS)
Amazon.com Common Stock (AMZN)
iShares US Treasury Bond Exchange Traded Fund (GOVT)
iShares Core S&P 500 Exchange Traded Fund (IVV)
ARK Innovation ETF Exchange Traded Fund (ARKK)
Rapid7 Common Stock (RPD)
AbbVie Common Stock (ABBV)
Regeneron Pharmaceuticals Common Stock (REGN)

View all positions for Hayden Royal

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
FMR
AQR Capital Management
Geode Capital Management
Citadel Advisors
Citigroup
Henderson Group
Hanna Zanoni
Dimensional Fund Advisors
Morgan Stanley
LSV Asset Management
Pacer Advisors

View all funds holding United Therapeutics Corporation